Completed OBSERVATIONAL NCT02111538

Body Composition in Systemic Amyloidosis (BIVAmyloid)

Prognostic Value of Phase Angle in Systemic Immunoglobulin Light-chain (AL) Amyloidosis

Sponsor: Akern Srl

Updated 10 times since 2017 Last updated: Apr 29, 2025 Started: Feb 28, 2014 Primary completion: Apr 30, 2019 Completion: Apr 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Amyloidosis and is currently completed. Akern Srl leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Jun 2025 — Present [monthly]

Completed
Sep 2024 — Jun 2025 [monthly]

Completed
Aug 2024 — Sep 2024 [monthly]

Completed
Jul 2024 — Aug 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed

▶ Show 5 earlier versions

Mar 2020 — Jan 2021 [monthly]

Completed

Status: Unknown Status → Completed
Jan 2020 — Mar 2020 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Jan 2020 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Akern Srl
Fondazione IRCCS Policlinico San Matteo di Pavia

Data source: Fondazione IRCCS Policlinico San Matteo di Pavia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pavia, Italy